Bullish Gator

Veeva Systems (VEEV)

Technical, fundamental, and sentiment analysis with recent related videos.

Stock Hub•Last Updated: 2026-10-26

Bullish Gator Rating
Bullish

VEEV rates Bullish overall. The fundamental read is bullish: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 20.01); revenue is growing about 14.1% per year; net income is growing about 23.6% per year. The technical picture is bullish: price is 55.9% above the 200-day moving average; 16.7% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 74/100), based on 6 news articles from recent coverage.

Fundamental Rating
Bullish

Revenue 3-year avg +14.1%. Net income 3-year avg +23.6%.

Technical Rating
Bullish

Price vs 20DMA +8.6%. RSI 76.17. Bollinger state: Inside Bands.

Sentiment Rating
Bullish

Composite score 74/100 from the AI judge, based on 6 news items, 0 television segments, and 0 videos.

Latest Market Read

All three badges are Bullish. Fundamentals show revenue averaged 14.1 percent per year and net income averaged 23.6 percent per year over three years, with no outlier distortion. Technicals show price 8.6 percent above the 20-day moving average (20-day MA) and the Relative Strength Index (RSI), a momentum reading, at 76.2 while the stock sits inside the Bollinger Bands, which supports the uptrend but raises the odds of a near-term pause given overbought RSI and below-average volume. Sentiment is Bullish, composite 74/100, reinforcing the overall Bullish rating.

Recent news: Coverage is broadly positive driven by a large commercial win: IQVIA adopted multiple Veeva clinical products (CTMS, eTMF, Study Startup, Site Connect) as enterprise standards and analysts flagged roughly 16% undervaluation alongside an AI roadmap, while Trefis cited raised guidance and an intact uptrend; the stock also had a modest 2.08% close-to-close gain. Against that, one piece argues the current share price largely prices in future cash flows and Emergence Capital distributed 250,000 shares, which could create selling pressure. Overall the deal momentum and analyst/guidance signals outweigh the valuation and share-distribution concerns in the near term.

Latest Videos

  • No qualified videos yet.